                         SEQUENCE LISTING

<110>  Phanes Therapeutics, Inc.
 
<120>  ANTI-TIP-1 ANTIBODIES AND USES THEREOF

<130>  689204-8WO

<150>  US62/640,123
<151>  2018-03-08

<160>  9     

<170>  PatentIn version 3.5

<210>  1
<211>  114
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  T2 Heavy Chain Variable Region

<400>  1

Glu Val Lys Leu Glu Gln Ser Gly Pro Glu Leu Lys Lys Pro Gly Glu 
1               5                   10                  15      


Thr Val Lys Ile Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Asp Tyr 
            20                  25                  30          


Ser Met His Trp Val Lys Gln Ala Pro Gly Lys Gly Leu Lys Trp Met 
        35                  40                  45              


Gly Trp Ile Asn Thr Lys Thr Arg Lys Pro Thr Tyr Ala Asp Asp Phe 
    50                  55                  60                  


Lys Gly Arg Phe Ala Phe Ser Leu Glu Thr Ser Ala Arg Thr Ala Tyr 
65                  70                  75                  80  


Leu Gln Ile Asn Asn Leu Lys Asn Glu Asp Thr Ala Thr Tyr Phe Cys 
                85                  90                  95      


Ala Pro Thr Gly Leu Asp Tyr Trp Gly Gln Gly Thr Ser Val Thr Val 
            100                 105                 110         


Ser Ser 
        


<210>  2
<211>  112
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  T2 Light Chain Variable Region

<400>  2

Asp Ile Val Ile Thr Gln Thr Thr Leu Thr Leu Ser Val Ser Ile Gly 
1               5                   10                  15      


Gln Pro Ala Ser Ile Ser Cys Lys Ser Ser Gln Ser Leu Leu Asp Ser 
            20                  25                  30          


Asp Gly Lys Thr Tyr Leu Asn Trp Leu Leu Gln Arg Pro Gly Gln Ser 
        35                  40                  45              


Pro Lys Arg Leu Ile Tyr Leu Val Ser Lys Leu Asp Ser Gly Val Pro 
    50                  55                  60                  


Asp Arg Phe Thr Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Lys Ile 
65                  70                  75                  80  


Ser Arg Val Glu Ala Glu Asp Leu Gly Val Tyr Tyr Cys Trp Gln Gly 
                85                  90                  95      


Thr His Phe Pro Arg Thr Phe Gly Gly Gly Thr Lys Leu Glu Ile Lys 
            100                 105                 110         


<210>  3
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  T2 HC CDR1

<400>  3

Gly Tyr Thr Phe Thr Asp Tyr Ser 
1               5               


<210>  4
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  T2 HC CDR2

<400>  4

Ile Asn Thr Lys Thr Arg Lys Pro 
1               5               


<210>  5
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  T2 HC CDR3

<400>  5

Ala Pro Thr Gly Leu Asp Tyr 
1               5           


<210>  6
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  T2 LC CDR1

<400>  6

Gln Ser Leu Leu Asp Ser Asp Gly Lys Thr Tyr 
1               5                   10      


<210>  7
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  T2 LC CDR2

<400>  7

Leu Val Ser 
1           


<210>  8
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  T2 LC CDR3

<400>  8

Trp Gln Gly Thr His Phe Pro Arg Thr 
1               5                   


<210>  9
<211>  124
<212>  PRT
<213>  Homo sapiens

<400>  9

Met Ser Tyr Ile Pro Gly Gln Pro Val Thr Ala Val Val Gln Arg Val 
1               5                   10                  15      


Glu Ile His Lys Leu Arg Gln Gly Glu Asn Leu Ile Leu Gly Phe Ser 
            20                  25                  30          


Ile Gly Gly Gly Ile Asp Gln Asp Pro Ser Gln Asn Pro Phe Ser Glu 
        35                  40                  45              


Asp Lys Thr Asp Lys Gly Ile Tyr Val Thr Arg Val Ser Glu Gly Gly 
    50                  55                  60                  


Pro Ala Glu Ile Ala Gly Leu Gln Ile Gly Asp Lys Ile Met Gln Val 
65                  70                  75                  80  


Asn Gly Trp Asp Met Thr Met Val Thr His Asp Gln Ala Arg Lys Arg 
                85                  90                  95      


Leu Thr Lys Arg Ser Glu Glu Val Val Arg Leu Leu Val Thr Arg Gln 
            100                 105                 110         


Ser Leu Gln Lys Ala Val Gln Gln Ser Met Leu Ser 
        115                 120                 


